Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-17

FDA Approved: RILUZOLE — Supplemental Application (Florida Pharmaceutical Products, LLC)

View source ↗

Summary

FDA approved a supplemental application for riluzole by Florida Pharmaceutical Products, LLC, confirming approval status for a generic riluzole product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Riluzole (riluzole)

Snippet

SUPPL AP for RILUZOLE (RILUZOLE)